- Feasibility studies: Evaluation of process scenarios for intended manufacturing demand, including facilities, equipment list, schedule, economic impact, and organizational chart.
- Risk assessment and implementation plan.
SAGA offers multiple possibilities to help companies to archive their goals. From conceptual design and business development to CGMP manufacturing. From remote consultation to the deployment of a well-trained CGMP crew to excel production and meet deadlines.
The new era (post COVID) challenges are still beyond full understanding, never before the world has acted as fast in terms of medical treatment, to the point of obtaining multiple vaccines and therapeutic treatments in less than two years. The responds from governments and privet sector easily exceeds the 2018-2028 landscape capabilities. The more notable limitations since COVID beginning (late 2019) are the raw materials and production footprints. Both challenges are in the scope and current plans of the the big pharma companies and governments. The consequences of these new capabilities create the perfect scenario for SAGA’s origin: “With that many new facilities and low chances to fail, the future of any company need to be run and operate by capable and knowable people”.
